Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
HK Stock MarketDetailed Quotes
CANSINOBIO (06185)
- 37.380
- -0.200-0.53%
Market Closed Jan 16 16:01 CST
9.23BMarket Cap-59.33P/E (TTM)
37.900High36.700Low913.40KVolume37.600Open37.580Prev Close33.95MTurnover0.69%Turnover RatioLossP/E (Static)247.04MShares56.55052wk High1.71P/B4.96BFloat Cap25.25052wk Low--Dividend TTM132.67MShs Float449.063Historical High--Dividend LFY3.19%Range %14.800Historical Low37.172Avg Price200Lot Size--Div Yield TTM--Div Yield LFY
CANSINOBIO (06185) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 22.13%692.57M | 31.07%374.09M | 20.02%137.16M | 138.97%824.88M | 222.88%567.08M | 1,253.60%285.42M | 13.65%114.28M | -66.52%345.18M | -75.17%175.63M | -96.65%21.09M |
| Operating income | 22.13%692.57M | 31.07%374.09M | 20.02%137.16M | 138.97%824.88M | 222.88%567.08M | 1,253.60%285.42M | 13.65%114.28M | -66.52%345.18M | -75.17%175.63M | -96.65%21.09M |
| Cost of sales | ---- | 21.13%-77.51M | ---- | 79.98%-244.43M | ---- | 87.68%-98.27M | ---- | -0.29%-1.22B | ---- | -154.31%-797.57M |
| Operating expenses | 8.50%-133.86M | 21.13%-77.51M | 48.64%-23.74M | 79.98%-244.43M | 15.30%-146.28M | 87.68%-98.27M | 29.08%-46.23M | -0.29%-1.22B | 28.54%-172.72M | -154.31%-797.57M |
| Gross profit | 32.78%558.71M | 58.47%296.58M | 66.67%113.42M | 166.26%580.45M | 14,344.25%420.79M | 124.10%187.15M | 92.41%68.05M | -369.45%-876.02M | -99.37%2.91M | -345.59%-776.49M |
| Selling expenses | -41.41%-277.22M | -39.00%-156.34M | -25.92%-58.66M | -4.43%-369.05M | -1.24%-196.04M | 12.70%-112.48M | 15.27%-46.59M | -32.55%-353.4M | -29.84%-193.63M | -44.93%-128.84M |
| Administrative expenses | 6.29%-110.05M | 11.41%-77.76M | 5.66%-34.97M | 33.99%-194.36M | 37.57%-117.43M | 37.33%-87.78M | 38.78%-37.07M | -5.89%-294.45M | 11.11%-188.09M | -0.30%-140.05M |
| Research and development expenses | 17.48%-224.67M | 20.50%-147.79M | 24.84%-72.71M | 34.78%-416.12M | 41.02%-272.27M | 45.06%-185.9M | 35.40%-96.75M | 18.02%-637.99M | 15.92%-461.67M | -4.45%-338.37M |
| Profit from asset sales | 281.80%42.96K | ---- | --84.72K | ---- | -163.08%-23.63K | ---- | ---- | ---- | --37.46K | ---- |
| Revaluation surplus | 157.01%4.1M | ---- | 229.10%2.7M | ---- | 53.23%-7.19M | ---- | -129.16%-2.09M | ---- | -379.50%-15.37M | ---- |
| -Changes in the fair value of other assets | 157.01%4.1M | ---- | 229.10%2.7M | ---- | 53.23%-7.19M | ---- | -129.16%-2.09M | ---- | -379.50%-15.37M | ---- |
| Impairment and provision | -9.52%-26.18M | 12.12%-12.36M | 28.24%-10.8M | -0.70%-15.15M | 97.02%-23.9M | 30.59%-14.06M | -16.94%-15.05M | -71.43%-15.05M | -50.46%-801.12M | -338.13%-20.26M |
| -Other impairment is provision | -9.52%-26.18M | 12.12%-12.36M | 28.24%-10.8M | -0.70%-15.15M | 97.02%-23.9M | 30.59%-14.06M | -16.94%-15.05M | -71.43%-15.05M | -50.46%-801.12M | -338.13%-20.26M |
| Special items of operating profit | 601.99%115.54M | 355.24%95.46M | 175.68%50.55M | -92.35%10.84M | -113.76%-23.02M | -160.73%-37.4M | -230.88%-66.79M | -5.26%141.72M | 44.00%167.28M | -19.13%61.58M |
| Operating profit | 113.15%29.72M | 99.12%-2.21M | 93.62%-12.66M | 80.18%-403.39M | 84.89%-225.94M | 81.34%-250.47M | -6.28%-198.26M | -48.69%-2.04B | -73.96%-1.5B | -714.58%-1.34B |
| Financing income | ---- | -67.97%17.33M | ---- | -31.74%82.35M | ---- | -38.87%54.09M | ---- | -46.75%120.64M | ---- | -36.10%88.49M |
| Financing cost | -765.59%-20.73M | -4.87%-34.42M | -116.37%-3.83M | 6.50%-60.16M | -96.12%3.11M | -11.65%-32.82M | 502.46%23.38M | -53.82%-64.34M | -62.52%80.29M | -92.87%-29.4M |
| Adjustment items of earning before tax | 82.44%-504.64K | ---- | -6,398.83%-111.76K | ---- | 92.94%-2.87M | ---- | 99.98%-1.72K | ---- | -3,128.89%-40.7M | ---- |
| Earning before tax | 103.76%8.49M | 91.58%-19.3M | 90.51%-16.59M | 80.74%-381.2M | 84.50%-225.7M | 82.14%-229.2M | 12.76%-174.88M | -67.14%-1.98B | -125.10%-1.46B | -2,988.28%-1.28B |
| Tax | 499.02%5.95M | 703.53%5.82M | --5.05M | -121.54%-2.47M | -228.18%-1.49M | -182.82%-964K | ---- | -94.78%11.45M | -99.26%1.16M | -97.98%1.16M |
| After-tax profit from continuing operations | 106.36%14.44M | 94.14%-13.49M | 93.40%-11.55M | 80.50%-383.67M | 84.38%-227.2M | 82.05%-230.16M | -2.75%-174.88M | -103.93%-1.97B | -197.72%-1.45B | -8,092.09%-1.28B |
| Earning after tax | 106.36%14.44M | 94.14%-13.49M | 93.40%-11.55M | 80.50%-383.67M | 84.38%-227.2M | 82.05%-230.16M | -2.75%-174.88M | -103.93%-1.97B | -197.72%-1.45B | -8,092.09%-1.28B |
| Minority profit | ---- | ---- | ---- | 99.01%-4.79M | 98.98%-4.79M | 98.91%-4.79M | 84.38%-4.79M | -776.08%-484.7M | -3,192.65%-469.89M | -11,683.23%-440.74M |
| Profit attributable to shareholders | 106.49%14.44M | 94.02%-13.49M | 93.21%-11.55M | 74.45%-378.88M | 77.42%-222.41M | 73.22%-225.37M | -21.89%-170.1M | -63.04%-1.48B | -107.63%-985.03M | -6,975.54%-841.43M |
| Basic earnings per share | 106.67%0.06 | 94.51%-0.05 | 92.75%-0.05 | 74.54%-1.53 | 77.44%-0.9 | 73.31%-0.91 | -21.05%-0.69 | -63.32%-6.01 | -107.81%-3.99 | -6,920.00%-3.41 |
| Diluted earnings per share | 106.67%0.06 | 94.51%-0.05 | 92.75%-0.05 | 74.54%-1.53 | 77.44%-0.9 | 73.31%-0.91 | -21.05%-0.69 | -63.32%-6.01 | -107.81%-3.99 | -6,920.00%-3.41 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
New Consumption Stocks New Consumption Stocks
New Consumption Stocks refer to emerging consumer companies that leverage innovative business models, digital technology, and personalized products to meet the emotional value and upgraded lifestyle demands of younger generations. New Consumption Stocks refer to emerging consumer companies that leverage innovative business models, digital technology, and personalized products to meet the emotional value and upgraded lifestyle demands of younger generations.
View More
Hot Topics Hot Topics
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde
年頭旺到年尾
Aug 21, 2025 06:11
Are you foolish? What's the point of knowing your mistakes?
牛牛課堂
Sep 12, 2025 17:29
[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?